[PDF] Top 20 Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol

... Theoretically, neoadjuvant therapy should have several clinical bene fi ts: (1) elimin- ation of possible micrometastasis, (2) improvement of R0 resection rate, (3) identi fi cation of patients with aggres- ... See full document

... pooled treatment effect using GRADE (Grading of Rec- ommendation, Assessment, development and Evaluation) rating system ...network meta-analysis, each treatment comparison has its own summary ... See full document

... This systematic review was developed by the Practice Guidelines Initiative (PGI) of Cancer Care Ontario's Pro- gram in Evidence-based Care ...trointestinal Cancer Disease Site Group (DSG) and ... See full document

... rectal cancer within 7 cm of the anal verge were suitable for cCR assessment; DRE accuracy in assessing this distance can reach 50% and is helpful for estimating ... See full document

... statistical analysis. This study was conducted on an intention-to-treat basis. Patients who dropped out, or who failed to receive multimodal treatment within, either SFadj or NAT pathways in the included ... See full document

... The treatment paradigm for CRLM is rapidly shifting to a more personalized approach so as to execute precision medicine ...validated clinical risk scores were described by Fong et ...undergoing ... See full document

... with pancreatic adenocarcinoma have a dismal ...with pancreatic adeno- carcinoma have disease that is potentially amenable to resection at the time of ...“Borderline resectable disease” was defined ... See full document

... of cancer cases, including tumor grade, differen- tiation, lymph node metastasis, diabetes sta- tus, and treatment, were not adjusted in some ...lower clinical evidence level and more uncontrollable ... See full document

... best treatment options and further improve the prognosis of the ...to cancer initiation, progression, invasion, and metastasis [4, ...breast, pancreatic, urothelial, renal cell cancers, and myeloma ... See full document

... Furthermore, despite the overall robust statistical evi- dence generated through this analysis, some limitations have been identified. First, among the studies we included, only three studies were randomized ... See full document

... study, resectable patients who were able to undergo resection after neoadjuvant therapy had a median OS of up to 30 ...with resectable tumors who were unable to undergo resection for various reasons ... See full document

... SF + AT group for resected BRPC patients (HR 0.67 [95% CI, 0.30–1.52]) with a total of 29 patients (17 vs 12). Given that the small sample size in the study by Jang et al. [9], we con- sider the trend is the same but the ... See full document

... 1 systematic review [22] reported data on severe cases of influenza A(H1N1)pdm09 infection treated with convalescent plasma (Table 3 and Supple- mentary Table ...Univariate analysis showed a signi fi ... See full document

... for Systematic Reviews of Interventions [16] ...The impact of in- dividual bias domains on study results at the endpoint and study levels will be ... See full document

... c). Meta-regression analysis showed that the only treat- ment effect modifier present for morning PEF was dose level (high versus low); however, high dose versus medium dose or high hose versus high-medium ... See full document

... Three hundred twenty- fi ve publications were found during the initial literature search. Of which, 47 were excluded for duplicate studies and 245 papers were excluded by reading their title and abstract (see the detail ... See full document

... the treatment of new onset atrial fibrillation comes from patients with chronic atrial fibrillation or post cardiac ...This protocol for a systematic review and network ... See full document

... reporting meta-analysis is pooling of data when there is considerable heterogeneity, which gave rise to false ...in meta-analy- sis was accessed through I 2 statistic, where a higher value of I 2 ... See full document

... This systematic review and meta-analysis dealt with the question as to a positive effect ensuing from the systemic administration and local drug delivery of the antibiotic AZM in the ... See full document

... The CA19-9 tumor antigen was initially described by Koprowski et al. as a colorectal cancer marker [16] and is currently the most clinically useful marker of pancre- atic cancer. Furthermore, CA19-9 is ... See full document